Summary
Uptake of open-source automated insulin delivery systems is increasing globally and there is growing real-world, user-driven evidence around the safety and effectiveness of these systems. This article in The Lancet Diabetes & Endocrinology seeks to provide, from an international perspective:
- a review of the current evidence
- a description of the technologies
- discussion of the ethical and legal considerations
- a healthcare consensus supporting the implementation of open-source systems in clinical settings, with detailed clinical guidance.
The authors make recommendations for key stakeholders involved in diabetes technologies, including developers, regulators, and industry.
Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals (13 November 2021)
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00267-9/fulltext#%20
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now